Beyond type 2 asthma biomarkers: risk stratification for NSAID-exacerbated respiratory disease.
Pérez-Pazos J, García-Sánchez A, Estravís M, Moreno-Jimenez E, Morgado N, Gómez-García M, Ramos-González J, Gil-Melcón M, Martín-García C, Muñoz-Bellido F, Sanz C, Isidoro-García M, Dávila I.
Pérez-Pazos J, et al. Among authors: sanz c.
ERJ Open Res. 2024 Aug 5;10(4):00909-2023. doi: 10.1183/23120541.00909-2023. eCollection 2024 Jul.
ERJ Open Res. 2024.
PMID: 39104947
Free PMC article.